Table 1.
Participant characteristics.
| Control | AD | p value | |
|---|---|---|---|
| n | 25 | 25 | |
| Age (yrs, mean ± SD) | 69.3 ± 7.5 | 71.3 ± 7.3 | 0.346 |
| Sex (% Female) | 72% (18/25) | 68% (17/25) | 0.785 |
| Clinical dementia rating (CDR) score | NA | ||
| 0–normal | 100% (25/25) | 0 | |
| 0.5–very mild dementia | 40% (10/25) | ||
| 1–mild dementia | 36% (9/25) | ||
| 2–moderate dementia | 24% (6/25) | ||
| APOE ε4 genotype | 20% (5/25) | 72% (18/25) | <0.001* |
| Ethnicity (% Caucasian) | 96% (24/25) | 92% (23/25) | 0.552 |
| BMI (kg/m2, median [IQR]) | 26.1 [24.3–33.2] | 26.0 [22.9–29.1] | 0.467 |
| Diabetes diagnosis | 2/25 | 2/25 | 1.000 |
| MIND Diet total score (mean ± SD) | 7.6 ± 2.2 | 6.6 ± 2.7 | 0.160 |
| Bristol stool scale score (mean ± SD) | 3.5 ± 1.7 | 3.8 ± 1.2 | 0.561 |